Pouchitis

Current Opinion in Gastroenterology

Volumn 20, Issue 4, 2004, Pages 341-344

  Åkerlund, Jan Erik ^a   Löfberg, Robert ^a,b  

^a DANDERYD HOSPITAL   (Sweden)

^b Sophiahemmet Hospital   (Sweden)

Author keywords

Ileal pouch anal anastomosis; Inflammatory bowel diseases; Prognosis; Treatment; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; GANCICLOVIR; INFLIXIMAB; METRONIDAZOLE; PRASTERONE; PREBIOTIC AGENT; PROBIOTIC AGENT; TACROLIMUS;

ABDOMINAL CRAMP; ANASTOMOSIS; ANTIMICROBIAL ACTIVITY; CLINICAL TRIAL; ENDOSCOPY; HUMAN; ILEITIS; NEOPLASM; PATHOGENESIS; PROGNOSIS; PROPHYLAXIS; QUALITY OF LIFE; RECTUM HEMORRHAGE; RECURRENT DISEASE; REVIEW; RISK; TREATMENT OUTCOME; ULCERATIVE COLITIS; URINARY URGENCY;

EID: 3042645075     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200407000-00007     Document Type: Review

References (27)

1. Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994, 69:409-415.
2. Shen B, Achkar J-P, Connor JT, et al.: Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748-753. A comparison of clinical symptoms, clinical symptoms plus endoscopy, and the PDAI in 55 symptomatic patients. The authors propose a modified PDAI.
3. Hassan I, Horgan AF, Nivatvongs S, et al.: Outcome of patients undergoing ileal pouch-anal anastomosis for left-sided chronic ulcerative colitis. J Gastrointest Surg 2003, 7:567-571.
4. Hata K, Watanabe T, Shinozaki M, et al.: Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003, 38:1055-1058.
5. Stucchi AF, Shebani KO, Leeman SE, et al.: A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus. Am J Physiol Gastrointest Liver Physiol 2003, 285:G1259-G1267.
6. Kuisma J, Mentula S, Luukkonen P, et al.: Factors associated with ileal mucosal morphology and inflammation in patients with ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2003, 46:1476-1483.
7. Gionchetti P, Amadini C, Rizzello F, et al.: Diagnosis and treatment of pouchitis. Best Pract Res Clin Gastroenterol 2003, 17:75-87. An excellent review. The authors have pioneered the use of probiotics in pouchitis and inflammatory bowel diseases.
8. Mahadevan U, Sandborn WJ: Diagnosis and management of pouchitis. Gastroenterology 2003, 124:1636-1650. An extensive and comprehensive review with key references. The authors have been seminal in the terminology and definitions of pouchitis.
9. Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193-1196.
10. Sambuelli A, Boerr L, Negreira S, et al.: Budesonide enema in pouchitis: a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002, 16:27-34.
11. Shen B, Chermock KM, Fazio VW, et al.: Cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal-pouch anastomosis. Am J Gastroenterol 2003, 98:2460-2467. An attempt to analyze the cost-effectiveness of different clinical approaches for patients with symptoms suggestive of pouchitis.
12. Kuisma J, Mentula S, Järvinen H, et al.: Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003 Feb 15, 17:509-515.
13. Laake KO, Line PD, Aabakken L, et al.: Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol 2003, 38:409-414.
14. Tamboli CP, Caucheteux C, Cortot A, et al.: Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003 Oct, 17:805-820. An in-depth review and discussion of this new concept in inflammatory bowel diseases.
15. Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2002, 124:1202-1209. Multicenter randomized controlled trial demonstrating the efficacy of VSL#3 during a 12-month study period.
16. Mann SD, Pitt J, Springall RG, et al.: Clostridium difficile infection: an unusual case of refractory pouchitis: report of a case. Dis Colon Rectum 2003, 46:267-270.
17. Colombel JF, Ricart E, Loftus EV Jr, et al.: Management of Crohn's disease of the ileoanal pouch with infliximab. Rev Esp Enferm Dig 2003, 95:465-470, 459-464.
18. Viscido A, Habib FI, Kohn A, et al.: Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003, 17:1263-1271.
19. de Oca J, Vilar L, Castellote J, et al.: Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease. Rev Esp Enferm Dig 2003, 95:465-470, 459-464 (English and Spanish).
20. Baumgart DC, Wiedenmann B, Dignass AU: Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003, 17:1273-1281.
21. Klebl FH, Bregenzer N, Rogler G, et al.: Treatment of pouchitis with dehydroepiandrosterone (DHEA): a case report. Z Gastroenterol 2003, 41:1087-1090.
22. Fruin AB, El-Zammer O, Stucchi AF, et al.: Colonic metaplasia in the ileal pouch is associated with inflammation and is not the result of long-term adaptation. J Gastrointest Surg 2003, 7:246-254.
23. Thompson-Fawcett MW, Marcus V, Redston M, et al.: Risk of dysplasia in long-term ileal pouches with chronic pouchitis. Gastroenterology 2001, 121:275-281. An important study regarding the risk of dysplasia and neoplasia in ileal pouches.
24. Herline AJ, Meisinger LL, Rusin LC, et al.: Is routine pouch surveillance for dysplasia indicated for ileoanal pouches? Dis Colon Rectum 2003, 46:156-159. A long-term follow-up study regarding the risk for dysplasia and neoplasia in ileal pouches.
25. Ståhlberg D, Veress B, Tribukait B, et al.: Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003, 46:770-778.
26. Negi SS, Chaudhary A, Gondal R: Carcinoma of pelvic pouch following restorative proctocolectomy: report of a case and review of the literature. Dig Surg 2003, 20:63-65.
27. Tulchinsky H, Hawley PR, Nicholls J: Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003, 238:229-234. An important study regarding the incidence and causes of late failure in patients with ulcerative colitis.